Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Electroacupuncture Treatment Combined With Standard Antiemetic Drugs for Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer Receiving Highly Emetogenic Chemotherapy

NCT05275569 is registered in ClinicalTrials.gov with Affiliated Hospital of Qinghai University as lead sponsor.

NCT NCT05275569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05275569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Electroacupuncture Treatment Combined With Standard Antiemetic Drugs for Chemotherapy-induced Nausea and Vomiting in Patients With Breast Cancer Receiving Highly Emetogenic Chemotherapy
Lead sponsor
Affiliated Hospital of Qinghai University
Phase
Not applicable
Overall status
Unknown status
Start date
March 15, 2022
Completion date
December 31, 2024
Enrollment
234 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer